Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 23;10(2):e0116472.
doi: 10.1371/journal.pone.0116472. eCollection 2015.

Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity

Affiliations

Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity

Dorota Smolarek et al. PLoS One. .

Abstract

Duffy Antigen Receptor for Chemokines (DARC) plays multiple roles in human health as a blood group antigen, a receptor for chemokines and the only known receptor for Plasmodium vivax merozoites. It is the target of the murine anti-Fy6 monoclonal antibody 2C3 which binds to the first extracellular domain (ECD1), but exact nature of the recognized epitope was a subject of contradictory reports. Here, using a set of complex experiments which include expression of DARC with amino acid substitutions within the Fy6 epitope in E. coli and K562 cells, ELISA, surface plasmon resonance (SPR) and flow cytometry, we have resolved discrepancies between previously published reports and show that the basic epitope recognized by 2C3 antibody is 22FEDVW26, with 22F and 26W being the most important residues. In addition, we demonstrated that 30Y plays an auxiliary role in binding, particularly when the residue is sulfated. The STD-NMR studies performed using 2C3-derived Fab and synthetic peptide corroborated most of these results, and together with the molecular modelling suggested that 25V is not involved in direct interactions with the antibody, but determines folding of the epitope backbone.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Inhibition of 2C3 MAb binding to ECD1-nuc.
The antibody was incubated with serially diluted DFEDVWNSSYG (circles) or DFEDVWNSSY(SO3H)G (squares) peptides. Subsequent binding to ECD1-nuc was evaluated by ELISA as described in Materials and Methods. The difference in % of inhibition was statistically significant in the range of concentrations 3-60 nM (P < 0.05, two-tailed Mann-Whitney U test).
Figure 2
Figure 2. Comparison of binding of 2C3 MAb and 2C3 Fab to ECD1-nuc evaluated by ELISA.
The binding of 2C3 MAb (squares) and 2C3 Fab (circles) was evaluated by ELISA as described in Materials and Methods. The difference in binding is statistically significant at concentration 20 nM (P < 0.05, two-tailed Mann-Whitney U test).
Figure 3
Figure 3. STD-NMR analysis of the Fab-binding epitope.
The STD NMR (bottom) and reference 1H NMR spectra of the peptide DFEDVWNSSYG (diagram) in the presence of Fab were acquired at 600 MHz and 25°C for samples (160μl, in a 3 mm tube) prepared in PBS made with 2H2O, pH 7.5. The protein was irradiated at δH 9.5 ppm (on-resonance) and δH30 ppm (off-resonance) with a saturation time of 2 s. The excitation sculpting pulse sequence was used to suppress water signals. The oversized one-letter amino acid codes indicate the proton resonances that were enhanced in the STD experiments. The Greek letters and numbers designate the enhanced resonances of the aromatic systems. The unresolved resonances are grouped.
Figure 4
Figure 4. Three-dimensional structure of the peptide DFEDVWNSSYG (a) and peptides in which Val-25 is substituted by amino acids of different hydrophobicity (b-d).
Peptide structures were calculated in PEP-FOLD and then visualized and analyzed in Chimera software. The amino acid residues involved in the antibody binding are visualized in red, while the residue that was changed: Val (a), Ile (b), Leu (c) and Ala (d) is visualized in purple.

Similar articles

Cited by

  • Duffy antigen is expressed during erythropoiesis in Duffy-negative individuals.
    Dechavanne C, Dechavanne S, Bosch J, Metral S, Redinger KR, Watson QD, Ratsimbasoa AC, Roeper B, Krishnan S, Fong R, Bennett S, Carias L, Chen E, Salinas ND, Ghosh A, Tolia NH, Woost PG, Jacobberger JW, Colin Y, Gamain B, King CL, Zimmerman PA. Dechavanne C, et al. Cell Host Microbe. 2023 Dec 13;31(12):2093-2106.e7. doi: 10.1016/j.chom.2023.10.019. Epub 2023 Dec 5. Cell Host Microbe. 2023. PMID: 38056457 Free PMC article.
  • VHH Structural Modelling Approaches: A Critical Review.
    Vishwakarma P, Vattekatte AM, Shinada N, Diharce J, Martins C, Cadet F, Gardebien F, Etchebest C, Nadaradjane AA, de Brevern AG. Vishwakarma P, et al. Int J Mol Sci. 2022 Mar 28;23(7):3721. doi: 10.3390/ijms23073721. Int J Mol Sci. 2022. PMID: 35409081 Free PMC article. Review.
  • MiR-29 Induces K562 Cell Apoptosis by Down-Regulating FoxM1.
    Wang X, Zhong H, Wang L, Dong Y, Jia A, Mo Q, Zhang C. Wang X, et al. Med Sci Monit. 2015 Oct 15;21:3115-20. doi: 10.12659/msm.894554. Med Sci Monit. 2015. PMID: 26470025 Free PMC article.

References

    1. Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10: 224–228. 10.1038/ng0695-224 - DOI - PubMed
    1. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302–304. 10.1056/NEJM197608052950602 - DOI - PubMed
    1. Mercereau-Puijalon O, Menard D (2010) Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol 17: 176–183. 10.1016/j.tracli.2010.06.005 - DOI - PubMed
    1. Batchelor JD, Zahm JA, Tolia NH (2011) Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol. 10.1038/nsmb.2088 - DOI - PMC - PubMed
    1. Batchelor JD, Malpede BM, Omattage NS, DeKoster GT, Henzler-Wildman KA, et al. (2014) Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC. PLoS Pathog 10: e1003869 10.1371/journal.ppat.1003869 - DOI - PMC - PubMed

Publication types